Francesca Pampaloni
Overview
Explore the profile of Francesca Pampaloni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Starace M, Mandel V, Ardigo M, Carpanese M, Quadrelli F, Pampaloni F, et al.
Dermatol Ther (Heidelb)
. 2025 Mar;
PMID: 40064753
Introduction: Literature about trichoscopy of permanent chemotherapy-induced alopecia (pCIA) is still scarce, while no data were published regarding reflectance confocal microscopy (RCM). The aim of our study is to monitor...
2.
Starace M, Rapparini L, Cedirian S, Quadrelli F, Pampaloni F, Bruni F, et al.
J Eur Acad Dermatol Venereol
. 2025 Feb;
PMID: 39898721
No abstract available.
3.
Starace M, Pampaloni F, Quadrelli F, Cedirian S, Rapparini L, Bruni F, et al.
Dermatol Ther (Heidelb)
. 2024 Dec;
15(1):223-226.
PMID: 39690381
Introduction: Alopecia areata (AA) is a non-scarring autoimmune disease characterized by patchy hair loss. The aim of this study was to validate a novel trichoscopic scoring tool, the Severity TRichoscopy...
4.
Starace M, Cedirian S, Quadrelli F, Pampaloni F, Brunetti T, Chessa M, et al.
Dermatol Pract Concept
. 2024 Dec;
14(4).
PMID: 39652913
Introduction: Dupilumab, a monoclonal antibody targeting IL-4 receptor subunit alpha, treats atopic dermatitis (AD) and may impact alopecia areata (AA). AA involves Th1-driven immune activity, and recent studies suggest a...
5.
Caldarola G, Raimondi G, Samela T, Pinto L, Pampaloni F, Starace M, et al.
Front Public Health
. 2024 Sep;
12:1415334.
PMID: 39220459
Objective: The prevalence of anxiety and depression in patients diagnosed with Alopecia Areata (AA) is very high and this significant burden of psychological symptoms threatens the Health-Related Quality of Life...
6.
Starace M, Cedirian S, Rapparini L, Quadrelli F, Pampaloni F, Bruni F, et al.
Dermatol Ther (Heidelb)
. 2024 May;
14(6):1457-1477.
PMID: 38822213
Frontal fibrosing alopecia (FFA) represents a distinctive form of primary lymphocytic scarring alopecia characterized by fronto-temporal hair recession and eyebrow hair loss. While predominantly affecting postmenopausal women, FFA also occurs...
7.
Piraccini B, Rapparini L, Quadrelli F, Alessandrini A, Bruni F, Cedirian S, et al.
Ital J Dermatol Venerol
. 2024 May;
159(3):336-343.
PMID: 38808459
Background: Alopecia areata (AA) is an organ-specific autoimmune disease that affects the hair follicles of the scalp and the rest of the body causing hair loss. Due to the unpredictable...
8.
Starace M, Pampaloni F, Lazaridou E, Kyrmanidou E, Stratigos A, Lallas A, et al.
Dermatol Ther (Heidelb)
. 2024 Apr;
14(4):953-970.
PMID: 38598171
Introduction: Alopecia areata (AA) affects approximately 2% of the general population and is associated with significant psychosocial morbidity and poor health-related quality of life. Despite the high incidence of the...
9.
Starace M, Rapparini L, Quadrelli F, Cedirian S, Pampaloni F, Piraccini B
J Eur Acad Dermatol Venereol
. 2024 Mar;
38(10):e861-e862.
PMID: 38459785
No abstract available.
10.
Vannuccini S, Meleca C, Toscano F, Mertino P, Pampaloni F, Fambrini M, et al.
Reprod Biomed Online
. 2024 Mar;
48(5):103768.
PMID: 38432071
Research Question: What is the prevalence of adenomyosis at ultrasonography among adolescents and young women reporting dysmenorrhoea and/or heavy menstrual bleeding (HMB)? Design: This observational cohort study involved adolescents and...